What is the proper administration protocol for phenytoin (antiepileptic medication)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Phenytoin Administration Protocol

For safe and effective administration of phenytoin, use a loading dose of 10-15 mg/kg IV at a maximum rate of 50 mg/min in adults, followed by maintenance doses of 100 mg orally or IV every 6-8 hours. 1

IV Administration Guidelines

Loading Dose

  • For adults with status epilepticus, administer 10-15 mg/kg IV at a rate not exceeding 50 mg/min (approximately 20 minutes for a 70-kg patient) 1
  • For children, administer 15-20 mg/kg IV at a rate not exceeding 1-3 mg/kg/min or 50 mg/min, whichever is slower 1
  • Therapeutic serum phenytoin levels (10-20 mcg/mL) are typically achieved within minutes after completion of the infusion 2

Administration Technique

  • Administer directly into a large peripheral or central vein through a large-gauge catheter 1
  • Test IV catheter patency with sterile saline flush before administration 1
  • Follow each injection with a sterile saline flush to avoid local venous irritation due to the solution's alkalinity 1
  • For infusion, dilute in normal saline with final concentration no less than 5 mg/mL 1
  • Use an in-line filter (0.22-0.55 microns) for infusion administration 1
  • Complete administration within 1-4 hours after preparation 1
  • Never add phenytoin to dextrose-containing solutions due to precipitation risk 1, 3

Monitoring During Administration

  • Continuous cardiac monitoring is essential during and after IV administration 1
  • Monitor vital signs closely, especially blood pressure and heart rate via ECG 3
  • Reduce infusion rate or discontinue if:
    • Heart rate decreases by 10 beats per minute 3
    • Hypotension develops 1
    • Cardiac arrhythmias occur 1
  • Monitor for neurological side effects including ataxia, nystagmus, tremor, and somnolence 2

Alternative: Fosphenytoin Administration

  • Fosphenytoin (a water-soluble prodrug of phenytoin) can be administered at 18 PE/kg IV at a maximum rate of 150 PE/min 3, 2
  • Fosphenytoin has fewer adverse events compared to IV phenytoin loading 3, 2
  • Therapeutic phenytoin levels are achieved within minutes after completion of the infusion 3
  • Intramuscular administration of fosphenytoin produces therapeutic serum phenytoin levels within 1 hour 2

Oral Administration

  • Oral loading of phenytoin can be administered as 20 mg/kg divided in maximum doses of 400 mg every 2 hours 2
  • Therapeutic serum phenytoin levels are typically achieved between 3-8 hours after initial ingestion 2
  • Maintenance oral dosing without loading can achieve therapeutic levels in 3-7 days 2

Therapeutic Monitoring

  • Therapeutic effect occurs most often with serum total concentrations between 10-20 mcg/mL (unbound phenytoin 1-2 mcg/mL) 1
  • Trough levels should be obtained just prior to the patient's next scheduled dose 1
  • Peak levels indicate threshold for dose-related side effects 1
  • For patients with renal or hepatic disease or hypoalbuminemia, monitor unbound phenytoin concentrations 1

Common Pitfalls and Cautions

  • Rapid IV administration can cause cardiovascular collapse, CNS depression, and cardiac arrest 1
  • IV phenytoin contains propylene glycol (40%) and ethanol (10%) with pH of 12, contributing to adverse effects 2
  • Purple glove syndrome, tissue necrosis, and phlebitis are potential complications of IV phenytoin 2
  • If refrigerated or frozen, undiluted phenytoin may form a precipitate (will dissolve at room temperature) 1
  • A faint yellow coloration may develop but does not affect potency 1

By following these guidelines, phenytoin can be administered safely and effectively while minimizing the risk of adverse events that could compromise patient outcomes.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Fosphenytoin Administration Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.